首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   295783篇
  免费   9093篇
  国内免费   455篇
耳鼻咽喉   2735篇
儿科学   9840篇
妇产科学   5020篇
基础医学   32054篇
口腔科学   3881篇
临床医学   24531篇
内科学   56255篇
皮肤病学   2549篇
神经病学   27994篇
特种医学   13025篇
外国民族医学   4篇
外科学   46104篇
综合类   4182篇
现状与发展   1篇
一般理论   167篇
预防医学   28731篇
眼科学   5608篇
药学   17937篇
  2篇
中国医学   795篇
肿瘤学   23916篇
  2023年   511篇
  2022年   832篇
  2021年   2072篇
  2020年   1229篇
  2019年   2023篇
  2018年   23919篇
  2017年   18881篇
  2016年   21150篇
  2015年   3272篇
  2014年   4177篇
  2013年   6029篇
  2012年   14511篇
  2011年   28825篇
  2010年   23035篇
  2009年   15786篇
  2008年   27013篇
  2007年   29720篇
  2006年   8785篇
  2005年   10658篇
  2004年   11407篇
  2003年   12176篇
  2002年   9929篇
  2001年   1427篇
  2000年   1312篇
  1999年   1380篇
  1998年   1891篇
  1997年   1615篇
  1996年   1240篇
  1995年   1241篇
  1994年   1035篇
  1993年   1015篇
  1992年   790篇
  1991年   785篇
  1990年   788篇
  1989年   693篇
  1988年   626篇
  1987年   582篇
  1986年   567篇
  1985年   693篇
  1984年   852篇
  1983年   850篇
  1982年   1187篇
  1981年   1052篇
  1980年   989篇
  1979年   466篇
  1978年   583篇
  1977年   551篇
  1976年   459篇
  1975年   414篇
  1974年   384篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
101.
Few effective regimens are available for patients with advanced multiple myeloma resistant to or relapsing after both alkylating agents and VAD. We treated 52 patients with advanced and refractory multiple myeloma with the combination of cyclophosphamide (3.0 g/m2) and etoposide (900 mg/m2) followed by GM-CSF at a daily dose of 0.125 mg/m2 until recovery of granulocytes. 42% of patients responded with a median time of 19 d for recovery of granulocytes to 0.5 x 109/1 and a 4% mortality rate. Eight responding patients received a second myeloablative treatment supported by either autologous bone marrow (six patients) or blood stem cells (two patients). The median survival time for all patients was 11 months and the median remission time for responding patients was 8 months. The combination of cyclophosphamide and etoposide provided an effective rescue treatment for many patients with advanced multiple myeloma resistant to conventional therapies. This programme also allowed early marrow or blood stem cell collection in support of subsequent myeloablative therapy for selected patients.  相似文献   
102.
103.
104.
Single-agent chemotherapy of metastatic breast cancer is the treatment of choice in patients with slow tumor progression and asymptomatic disease. In this patient group, the choice of drugs is based more on good tolerability than on efficacy. By contrast, symptomatic or rapidly progressing disease requires the use of highly active regimens where more weight is put on reliable antitumor activity. While anthraycline-based combination regimens have set the standard of effective treatment, the addition of docetaxel (and to a lesser extent paclitaxel) has improved tumor response, but failed to induce a consistent prolongation of survival. Based on retrospective analyses, it is hypothesised that the combined use of anthracyclines and taxanes in first-line therapy may be most beneficial in defined subgroups: after adjuvant chemotherapy, in patients with HER-2 gene amplification, possibly also in patients with rapidly progressing visceral disease.  相似文献   
105.
Research investigating predictors of risky sexual behavior of rural MSM is sparse, even though the prevalence of HIV in rural areas has increased. This study explored two sets of predictors of 93 rural MSM's levels of risky sexual behavior: mental health variables and stigma emanating from men's family members, health care professionals, and people in the rural communities in which they live. Over 47% of the men were found to be at modified high to high risk. Logistic regression using a continuation logit model was used to test the relationship of the predictor variables and the four levels of risk. Findings indicate that self-esteem was predictive of the highest sexual risk behavior but not lower levels of risk. Stigma was predictive of modified high sexual risk when compared to low and no risk categories. No variables differentiated men at low risk from men at no risk.  相似文献   
106.
107.
Grief     
  相似文献   
108.
109.
110.
Antegrade interlocking nailing of humeral shaft fractures   总被引:5,自引:0,他引:5  
The results of 39 humeral shaft fractures (37 patients) treated with antegrade locked nailing using a Russell–Taylor nail were reviewed. There were 30 acute fractures, 6 fractures malaligned in a hanging cast or brace, and 3 pathological fractures. Patient age ranged from 26 to 80 years (average, 59.7 years) and average follow-up was 25.7 months (range, 6–48 months). Fracture union was achieved in 92.3% of our cases, while shoulder function was excellent or good in 87.2% of cases. Antegrade locked nailing offers a dependable solution for the treatment of humeral shaft fractures, especially in polytrauma patients and cases of segmental or pathological fractures. Far less satisfactory results were obtained in comminuted fractures of the proximal third in the humerus, especially in osteoporotic patients, and we therefore advocate caution with the use of intramedullary nailing in this type of fracture. Certain technical aspects such as avoiding nailing the fracture in distraction, properly countersinking the tip of the nail, and achieving adequate fixation stability have been found to be of paramount importance to reduce the incidence of delayed union/non-union rate and to obtain better functional results from the shoulder joint.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号